Clinical Impacts of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Limb Threatening Ischaemia Undergoing Endovascular Therapy: Results of the SIRIUS Study | Synapse
March 3, 2026
Clinical Impacts of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Limb Threatening Ischaemia Undergoing Endovascular Therapy: Results of the SIRIUS Study
Key Points
Improved glycaemic control leads to better treatment outcomes for patients with chronic limb threatening ischaemia.
The study presents vital evidence on the role of sodium-glucose cotransporter 2 inhibitors in managing diabetes and limb conditions.
Analysis showcases data collected from diabetic patients undergoing endovascular therapy, emphasizing the relevance of glycaemic management.
Findings may help shape new treatment strategies for diabetic patients at risk of limb-threatening ischaemia.